CSBR Stock Analysis: Buy, Sell, or Hold?
CSBR - Champions Oncology, Inc.
$6.21
0.19 (3.16%)
▲
5d:
+3.67%
30d:
+0.49%
90d:
+4.37%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Mar 17, 2026
0d
Get Alerted When CSBR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CSBR shows positive signals but monitor for confirmation. Market pricing in 3.4% growth. Moderate conviction.
💡 BUY OPPORTUNITY: CSBR shows positive signals but monitor for confirmation. Market pricing in 3.4% growth. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CSBR is currently trading at $6.21, which is considered extended relative to its 30-day fair value range of $5.84 to $6.11. From a valuation perspective, the stock is trading at a premium (Forward PE: 62.1) compared to its historical average (56.2). At these levels, the market is pricing in 3.4% annual earnings growth.
Technical Outlook: Technically, CSBR is in a strong downtrend. The price is approaching resistance at $6.39. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: CSBR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.00 (+93.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CSBR is in a strong downtrend. The price is approaching resistance at $6.39. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: CSBR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.00 (+93.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.84 -
$6.11
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading 93.2% below Wall St target ($12.00)
- BULLISH: Expecting earnings turnaround to 3.4% growth with -2.8% revenue growth
Trading Range Analysis
30-Day Trading Range
$5.84 -
$6.11
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$5.82
Resistance Level
$6.39
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
62.10
Wall Street Target
$12.00
(+93.2%)
Revenue Growth (YoY)
-2.8%
Earnings Growth (YoY)
-61.1%
Profit Margin
-4.0%
Valuation Premium vs History
+3.4% premium
PE vs Historical
62.1 vs 56.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.4%
(market-implied from PE analysis)
1-Year Target
$6.42
(+3%)
2-Year Target
$6.64
(+7%)
3-Year Target
$6.87
(+11%)
3-Yr Target (if PE normalizes)
(PE: 62→56)
PE COMPRESSION
$6.21
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 62.1, Growth: -16.7%)
$4.53
(+-27%)
Base:
(SPY PE: 22.0, Growth: -16.7%)
$1.61
(-74%)
Bear:
(PE: 18.7, Growth: -16.7%)
$1.37
(-78%)
Share & Embed Analysis
Last updated: May 15, 2026 9:35 AM ET
Data refreshes hourly during market hours. Next update: 10:35 AM
Data refreshes hourly during market hours. Next update: 10:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CSBR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 60 BUY |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 50 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 59 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 65 BUY |
